Pharmaceuticals and personal care products (PPCPs) residues are known to occur widely in
the aquatic environments of industrialized and developing countries. Considerable progress …

The pollution of the aquatic environment has become a worldwide problem. The widespread
use of pesticides, heavy metals and pharmaceuticals through anthropogenic activities has …

Pharmaceutical compounds, such as antibiotics, nonsteroidal anti-inflammatory drugs
(NSAIDs), anticonvulsants, β-blocker, etc. have emerged as new classes of water pollutants …

Active pharmaceutical ingredients, especially antibiotics, are micropollutants whose
continuous flow into hydrological cycles has the potential to mediate antibiotic resistance in …

Several advanced treatments, such as ozonation or activated carbon adsorption, are
currently considered for the removal of organic micropollutants (OMPs) in wastewater …

Pharmaceutical is one of the noteworthy classes of emerging contaminants. These
biologically active compounds pose a range of deleterious impacts on human health and the …

In the last decades an increasing number of studies has been published concerning
contamination of aquatic ecosystems with pharmaceuticals. Yet, the distribution of these …

Quantification of drugs residues in wastewaters of different sources could help better
understand contamination pathways, eventually leading to effluent regulation. However …

Detection and quantification of Pharmaceutical and Personal care products (PPCPs) in
wastewaters and aqueous samples is crucial in terms of environmental monitoring and risk …

In the past few decades, there has been a rapid growth in the number of published articles
that have focused on the environmental monitoring of non-steroidal anti-inflammatory drugs …